Patent details

Basic Information

Publication number:

EP2590963

PCT Application Number:

PCT/EP/2011/061168

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP117288621

PCT Publication Number:

WO/2012/004207

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

(3-METHYLPYRROLIDIN-3-YL)METHYL PYRIDINYL ETHER DERIVATIVES AND THEIR USE AS NK-3 RECEPTOR ANTAGONISTS

French Title of Invention:

DÉRIVÉS DE (3-MÉTHYLPYRROLIDIN-3-YL)MÉTHYL PYRIDINYL ÉTHER ET LEUR UTILISATION EN TANT QU'ANTAGONISTES DU RÉCEPTEUR NK-3

German Title of Invention:

(3-METHYLPYRROLIDIN-3-YL)METHYL-PYRIDINYL-ETHER DERIVATE UND IHRE VERWENDUNG ALS NK-3 REZEPTOR ANTAGONISTEN

SPC Number:

Dates

Filing date:

04/07/2011

Grant date:

03/12/2014

EP Publication Date:

03/12/2014

PCT Publication Date:

12/01/2012

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

15/05/2013

EP B1 Publication Date:

03/12/2014

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

04/07/2015

Expiration date:

04/07/2031

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

04/07/2011

 

 

Name:

F.Hoffmann-La Roche AG

Address:

Grenzacherstrasse 124, 4070 Basel, Switzerland (CH)

Inventor

1

Name:

VIFIAN Walter

Address:

Switzerland (CH)

2

Name:

RATNI Hasane

Address:

France (FR)

3

Name:

NETTEKOVEN Matthias

Address:

Germany (DE)

Priority

Priority Number:

10168688

Priority Date:

07/07/2010

Priority Country:

European Patent Office (EPO) (EP)

Classification

Main IPC Class:

C07D 401/12;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages